Hi. Richter et al., SUCCESSFUL MONOTHERAPY OF SEVERE AND INTRACTABLE ATOPIC-DERMATITIS BYPHOTOPHERESIS, Journal of the American Academy of Dermatology, 38(4), 1998, pp. 585-588
Background: Patients with chronic atopic dermatitis can become unrespo
nsive to standard immunosuppressive therapy and thus pose a serious th
erapeutic problem. Objective: Our purpose was to evaluate the therapeu
tic effectiveness of photopheresis in the management of patients with
severe and intractable atopic dermatitis. Methods: Photopheresis was u
sed as monotherapy in patients (n = 3) who previously did not respond
to treatment with glucocorticosteroids, cyclosporine, phototherapy, or
photochemotherapy. Patients were treated at 2-week intervals (total n
umber of treatments = 10). Results: In all patients, photopheresis ind
uced clinical improvement and reduction of elevated serum levels of eo
sinophil cationic protein and total IgE. Prolongation of the intervals
between treatments from 2 to 4 weeks caused worsening in one patient,
whereas shortening of treatment-free intervals improved both clinical
and laboratory findings. Conclusion: These studies indicate that phot
opheresis may be used as monotherapy for the treatment of patients wit
h severe atopic dermatitis that has become intractable to standard the
rapeutic modalities.